Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer - Non Small Cell Non-Squamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022
What this trial is testing

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more
Indaptus Therapeutics, Inc 120
Testing effectiveness (Phase 2)UnknownNCT03382795
What this trial is testing

Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients

Who this might be right for
EGFR Positive Non-small Cell Lung Cancer
Korea University Guro Hospital 63
Testing effectiveness (Phase 2)Study completedNCT00042679
What this trial is testing

Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Who this might be right for
Carcinoma, Non-Small-Cell LungPulmonary NeoplasmsNeoplasms, Lung
Eli Lilly and Company
Testing effectiveness (Phase 2)UnknownNCT03994393
What this trial is testing

Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.

Who this might be right for
EGFR Mutant Advanced Non Small Cell Lung Cancer
University of Sydney 100
Testing effectiveness (Phase 2)UnknownNCT03461185
What this trial is testing

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Early research (Phase 1)Not Yet RecruitingNCT07036185
What this trial is testing

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

Who this might be right for
Gastric/Gastroesophageal Junction CancerBreast CancerColorectal Cancer+3 more
Shanghai Bao Pharmaceuticals Co., Ltd. 66
Large-scale testing (Phase 3)Active Not RecruitingNCT05047250
What this trial is testing

Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 60
Not applicableStudy completedNCT04694846
What this trial is testing

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Who this might be right for
Lung Non-Small Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Thomas Jefferson University 19
Testing effectiveness (Phase 2)Study completedNCT05865990
What this trial is testing

HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease

Who this might be right for
Metastatic Breast CancerAdvanced Non-Small Cell Squamous Lung CancerSolid Tumor, Adult
MedSIR 63
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Early research (Phase 1)Study completedNCT01520389
What this trial is testing

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Who this might be right for
Advanced Solid TumorsColorectal CancerSquamous Cell Head and Neck Cancer+2 more
Merrimack Pharmaceuticals 112
Large-scale testing (Phase 3)Looking for participantsNCT06793215
What this trial is testing

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerKRAS G12C Lung Cancer
Hoffmann-La Roche 600
Testing effectiveness (Phase 2)Study completedNCT03049618
What this trial is testing

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Who this might be right for
ALK Gene MutationBRAF Gene MutationEGFR Gene Mutation+9 more
University of Southern California 42
Early research (Phase 1)Study completedNCT00033410
What this trial is testing

Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
California Cancer Consortium 30
Testing effectiveness (Phase 2)UnknownNCT00398385
What this trial is testing

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 170
Early research (Phase 1)Looking for participantsNCT07623369
What this trial is testing

A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Huahui Health 299
Not applicableNo Longer AvailableNCT02475382
What this trial is testing

Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen

Who this might be right for
Squamous Non-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01047059
What this trial is testing

Molecular Imaging With Erlotinib and Bevacizumab

Who this might be right for
Non-Small-Cell Lung Carcinoma
University of Cologne 40
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Next Page